|
09/05/2024
|
07:00
|
Cancellation - e-Therapeutics Plc
|
RNS
|
|
08/05/2024
|
07:00
|
Last Day of Dealings on AIM
|
RNS
|
|
03/05/2024
|
18:00
|
e-therapeutics
|
RNS
|
|
29/04/2024
|
14:09
|
Result of General Meeting
|
RNS
|
|
10/04/2024
|
07:00
|
Proposed Fundraise of £28.9m and Cancellation
|
RNS
|
|
31/01/2024
|
16:30
|
Total Voting Rights
|
RNS
|
|
24/01/2024
|
10:04
|
Exercise of Options and Issue of Equity
|
RNS
|
|
16/01/2024
|
07:00
|
Business Update
|
RNS
|
|
09/01/2024
|
16:04
|
Director Dealing and Issue of Equity
|
RNS
|
|
27/12/2023
|
07:00
|
Update on OTCQX Market Listing
|
RNS
|
|
13/11/2023
|
09:05
|
Edison issues update on e-therapeutics (ETX): More to come in RNAi therapy discovery
|
EQS Group
|
|
02/11/2023
|
07:00
|
Strategic RWE collaboration with Arcturis
|
RNS
|
|
26/10/2023
|
07:38
|
Interim results for the six months to 31 July 2023
|
RNS
|
|
19/10/2023
|
09:54
|
Notice of Interim Results
|
RNS
|
|
20/09/2023
|
07:00
|
Senior Management Update
|
RNS
|
|
07/09/2023
|
11:47
|
Exercise of Options and Issue of Equity
|
RNS
|
|
31/07/2023
|
16:30
|
Total Voting Rights
|
RNS
|
|
18/07/2023
|
16:20
|
Result of Annual General Meeting
|
RNS
|
|
06/07/2023
|
17:27
|
Director Dealing and Issue of Equity
|
RNS
|
|
11/05/2023
|
07:00
|
Notice of AGM and Posting of Annual Report
|
RNS
|
|
04/05/2023
|
07:00
|
Final results for the year ended 31 January 2023
|
RNS
|
|
28/04/2023
|
16:30
|
Total Voting Rights
|
RNS
|
|
27/04/2023
|
07:00
|
Notification of Full Year Results Date
|
RNS
|
|
28/03/2023
|
15:57
|
Exercise of Options and Issue of Equity
|
RNS
|
|
21/02/2023
|
16:35
|
Price Monitoring Extension
|
RNS
|
|
20/02/2023
|
10:19
|
Director/PDMR Shareholding
|
RNS
|
|
07/02/2023
|
07:00
|
Filing of four patent applications
|
RNS
|
|
31/01/2023
|
07:00
|
Total Voting Rights
|
RNS
|
|
04/01/2023
|
15:15
|
Director Dealing and Issue of Equity
|
RNS
|
|
29/12/2022
|
16:40
|
Second Price Monitoring Extn
|
RNS
|
|
29/12/2022
|
16:35
|
Price Monitoring Extension
|
RNS
|
|
20/12/2022
|
16:35
|
Price Monitoring Extension
|
RNS
|
|
31/10/2022
|
07:00
|
Total Voting Rights
|
RNS
|
|
12/10/2022
|
15:12
|
Holding(s) in Company
|
RNS
|
|
11/10/2022
|
10:42
|
Holding(s) in Company
|
RNS
|
|
10/10/2022
|
08:03
|
Holding(s) in Company
|
RNS
|
|
30/09/2022
|
07:00
|
Interim results for the six months to 31 July 2022
|
RNS
|
|
30/09/2022
|
07:00
|
Fundraise of £13.5 million by way of Subscription
|
RNS
|
|
26/09/2022
|
16:40
|
Second Price Monitoring Extn
|
RNS
|
|
26/09/2022
|
16:36
|
Price Monitoring Extension
|
RNS
|
|
01/08/2022
|
07:00
|
Filing of eight patent applications
|
RNS
|
|
29/07/2022
|
07:00
|
Total Voting Rights
|
RNS
|
|
20/07/2022
|
10:39
|
Result of Annual General Meeting
|
RNS
|
|
06/07/2022
|
07:00
|
Notice to Shareholders - AGM Virtual Access
|
RNS
|
|
05/07/2022
|
07:00
|
Director Dealing and Issue of Equity
|
RNS
|
|
17/05/2022
|
07:00
|
Notice of AGM and Posting of Annual Report
|
RNS
|
|
04/05/2022
|
07:00
|
Final results for the year ended 31 January 2022
|
RNS
|
|
27/04/2022
|
07:00
|
Notification of Full Year Results Date
|
RNS
|
|
12/04/2022
|
07:00
|
Key Milestone Achieved on Galapagos Collaboration
|
RNS
|
|
05/04/2022
|
07:00
|
Immuno-Oncology Research Collaboration with iTeos
|
RNS
|